Skip to main content
logo
CHO Pharma, Inc. (TPEX:6586)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
110.50
-1.50 (-1.34%)
Aug 26, 2026, 1:54 PM CST

CHO Pharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
23,9696,01411,02214,83025,20415,354
Market Cap Growth
176.54%-45.44%-25.68%-41.16%64.15%235.65%
Enterprise Value
22,0163,8098,56813,94424,03313,969
Last Close Price
112.0028.1051.5069.30137.0083.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
14058.174202.443078.64-420067.124300.98
PB Ratio
10.102.444.014.9917.648.80
P/TBV Ratio
12.272.944.745.8327.0612.44

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-2661.502393.25-400545.333912.99

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.01-0.010.02
Net Debt / Equity Ratio
-0.82-0.83-0.85-0.87-0.72-0.74
Net Debt / EBITDA Ratio
6.686.539.8310.403.186.99
Net Debt / FCF Ratio
7.827.0810.498.883.996.59
Asset Turnover
0.000.000.00-00.00
Quick Ratio
21.3218.9620.4124.576.199.89
Current Ratio
21.9619.4720.8124.936.3910.06
Return on Equity (ROE)
-10.71%-11.13%-7.41%-13.90%-21.33%-11.11%
Return on Assets (ROA)
-7.24%-7.47%-5.22%-7.17%-12.55%-6.52%
Return on Capital Employed (ROCE)
-12.70%-13.20%-9.00%-9.00%-24.50%-12.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.12%-4.82%-1.93%-2.06%-1.34%-1.34%
FCF Yield
-1.04%-4.80%-2.02%-1.98%-1.03%-1.28%
Buyback Yield / Dilution
0.43%--11.86%-4.00%-0.04%-0.12%